The familial hyperchylomicronaemia syndrome

Area of Science:

• Lipoprotein metabolism
• Hereditary metabolic disorders
• Gastroenterology

Background:

• Familial hyperchylomicronaemia syndrome is a genetic disorder affecting lipoprotein metabolism.
• It results from lipoprotein lipase (LPL) deficiency, apolipoprotein (apo) CII deficiency, or LPL inhibition.
• Characterized by hyperchylomicronaemia, it can lead to severe pancreatitis and eruptive xanthomas.

Purpose of the Study:

• To describe the clinical course of a patient with acute pancreatitis caused by hereditary LPL deficiency.
• To discuss the various causes of familial hyperchylomicronaemia syndrome.
• To review current therapeutic strategies and molecular defects.

Main Methods:

• Case report detailing a patient's clinical presentation and management.
• Literature review on the causes, clinical features, and treatment of familial hyperchylomicronaemia syndrome.
• Update on the molecular basis of the disorder.

Main Results:

• The case highlights acute pancreatitis as a severe manifestation of hereditary LPL deficiency.
• The study reviews the spectrum of causes for familial hyperchylomicronaemia.
• Effective management relies on strict, lifelong dietary fat restriction.

Conclusions:

• Familial hyperchylomicronaemia syndrome necessitates lifelong low-fat dietary management to prevent recurrent hypertriglyceridemia and pancreatitis.
• Understanding the molecular defects is key to advancing therapeutic approaches.
• Early diagnosis and management are vital to avoid life-threatening complications like necrotizing pancreatitis.